Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MBX Biosciences (MBX) Cash from Investing Activities (2023 - 2026)

MBX Biosciences has reported Cash from Investing Activities over the past 4 years, most recently at -$97.1 million for Q1 2026.

  • Quarterly results put Cash from Investing Activities at -$97.1 million for Q1 2026, down 3109.83% from a year ago — trailing twelve months through Mar 2026 was -$184.0 million (down 6.5% YoY), and the annual figure for FY2025 was -$83.7 million, up 47.88%.
  • Cash from Investing Activities reached -$97.1 million in Q1 2026 per MBX's latest filing, up from -$130.0 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $26.0 million in Q2 2025 and bottomed at -$130.0 million in Q4 2025.
  • Median Cash from Investing Activities over the past 4 years was -$18.4 million (2023), compared with a mean of -$37.0 million.
  • The largest annual shift saw Cash from Investing Activities soared 429.31% in 2025 before it crashed 3109.83% in 2026.
  • Over 4 years, Cash from Investing Activities stood at -$29.0 million in 2023, then plummeted by 132.59% to -$67.3 million in 2024, then crashed by 93.0% to -$130.0 million in 2025, then increased by 25.29% to -$97.1 million in 2026.
  • Business Quant data shows Cash from Investing Activities for MBX at -$97.1 million in Q1 2026, -$130.0 million in Q4 2025, and $17.1 million in Q3 2025.